Apolipoprotein H (APOH) is a plasma protein with critical roles in coagulation regulation, lipid metabolism, and immune modulation. The bovine variant, APOH Bovine, is purified from fetal calf serum (FCS) and shares structural and functional homology with human APOH. It is commercially available as a recombinant protein or purified antigen, primarily used in biomedical research to study thrombosis, inflammation, and lipid-related diseases .
APOH Bovine is a glycosylated protein with a molecular weight of approximately 70 kDa (purified form) or 37.8 kDa (calculated from amino acid sequence) . Key features include:
Four Sushi (CCP/SCR) domains: Enable binding to negatively charged molecules like phospholipids, heparin, and dextran sulfate .
Signal peptide: 19-amino-acid sequence directing secretion .
Mature protein: 326 amino acids in bovine APOH, showing 89% homology to human and 86% to rat APOH .
APOH Bovine exhibits multifaceted biological activities:
Coagulation Regulation:
Immune Modulation:
Lipid Metabolism:
APOH Bovine is employed in diverse experimental contexts:
Therapeutic Studies: Recombinant APOH administration in murine sepsis models reduced mortality, organ injury, and inflammation, highlighting potential therapeutic applications .
Coagulation Pathway Analysis: Used to study antiphospholipid antibody interactions and thrombosis mechanisms .
Lipoprotein Research: Investigates lipid metabolism and reverse cholesterol transport .
Sepsis Protection:
Structural Insights:
Clinical Relevance:
Apolipoprotein-H is a glycoprotein with a molecular weight of approximately 70 kDa . It attaches to numerous negatively charged substances, such as phospholipids and dextran sulfate . This binding capability allows APOH to prevent the activation of the intrinsic blood coagulation cascade by attaching to phospholipids on the surface of damaged cells .
APOH is involved in regulating several biological processes, including:
Research into APOH has highlighted its potential therapeutic value. For example, in sepsis treatment, APOH has been shown to inhibit M1 polarization in macrophages by suppressing the toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway . This suggests that APOH could be a valuable target for therapeutic interventions in inflammatory and immune-related conditions.